昊海生科 (688366)
Shanghai Haohai Biological Technology Co., Ltd.
K-Line Chart
No K-line data available
Company NameShanghai Haohai Biological Technology Co., Ltd.
Listing Date2019-10-30
Issue Price89.23RMB
Registered Capital23319.369510k RMB
Legal RepresentativeHou Yongtai
Registered AddressNo. 5 Dongjing Road, Songjiang Industrial Zone, Shanghai
IndustryMedical Devices
Main BusinessMainly engaged in the research and development, production, and sales of biomedical materials, covering four core areas: ophthalmology, plastic aesthetics and wound care, orthopedics, anti-adhesion and hemostasis.
Company ProfileHaohai Biological Technology (06826.HK) is a high-tech biomedical enterprise focusing on the R&D, production, and sales of medical biomaterials. The company strategically focuses on rapidly growing therapeutic areas within the medical biomaterials market, including ophthalmology, plastic aesthetics and wound care, orthopedics, anti-adhesion and hemostasis. Its current product portfolio primarily includes intraocular lens series, medical sodium hyaluronate/sodium hyaluronate series, medical chitosan series, medical collagen sponge series, and topical recombinant human epidermal growth factor series. Among these, based on sales volume of intraocular lenses and the number of cataract surgeries performed nationwide, the company held approximately a 30% share of the Chinese intraocular lens market in 2017. Furthermore, the company has long maintained a leading position in specific segments such as surgery, ophthalmology, and orthopedics. According to a research report released by Guangzhou Biaodian Pharmaceutical Information Co., Ltd. in 2018, Haohai Biological Technology's market shares for surgical anti-adhesion agents, ophthalmic viscosurgical devices (OVDs), and orthopedic intra-articular viscosupplements reached 49.05%, 45.93%, and 36.21% respectively in 2017.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- Commercial vehicle manufacturing
- Passenger vehicle manufacturing
- Automotive parts manufacturing and sales
3. Company Basic Information
- Company Name: Dongfeng Automobile Co., Ltd.
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: Dongfeng Automobile Co., Ltd. (Stock Code: 600006) was established in 1999 and is a controlled subsidiary of Dongfeng Motor Group Co., Ltd. The company is primarily engaged in the research, development, production, and sales of commercial vehicles, passenger vehicles, and automotive parts.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital Management, Ltd. | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Council for Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2,000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities Co., Ltd. | Securities Firm | 1,500 | 3.1 |
| 8 | Guotai Junan Securities Co., Ltd. | Securities Firm | 1,200 | 2.4 |
| 9 | China Merchants Bank Co., Ltd. | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- New Energy Vehicles
- Fuel Cell
- Huawei Auto
- Vehicle Networking (V2X)
- Intelligent Transportation
- Autonomous Driving
- Hydrogen Energy
- Carbon Neutrality
Remarks
- Data update date: Latest financial report date (Specific date not provided, please refer to public information)
- Data source: Public market information